ZYME

Value 2022202320242025 TTM Total revenue 412.48 M76.01 M76.3 M105.97 M 81.26 M Gross profit 412.48 M76.01 M76.3 M105.97 M 81.26 M Operating expenses 281.95 M214.06 M213.41 M198.51 M 195.32 M Selling/general/admin expenses 73.36 M70.45 M61.51 M61.51 M 59.6 M Research & development 208.6 M143.62 M151.91 M137 M 135.72 M Operating income 130.53 M-138.05 M-137.11 M-92.55 M -114.05 M Non-Operating Income, Total 1.11 M-894 K558 K-559 K -488 K Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses 1.15 M-1.19 M776 K-610 K -488 K Unusual income/expense -42 K291 K-218 K51 K — Pretax income 135.23 M-119.24 M-116.61 M-79.75 M -103.97 M Equity in earnings ———— — Taxes 10.89 M-568 K6.08 M1.38 M -1.31 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 124.34 M-118.67 M-122.69 M-81.13 M -102.66 M Discontinued operations ———— — Net income 124.34 M-118.67 M-122.69 M-81.13 M -102.66 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 124.11 M-118.67 M-122.56 M-81.33 M -102.73 M Basic earnings per share (Basic EPS) 1.91-1.72-1.62-1.08 -1.37 Diluted earnings per share (Diluted EPS) 1.9-1.72-1.62-1.08 -1.37 Average basic shares outstanding 65.19 M68.86 M75.85 M75.4 M — Diluted shares outstanding 65.25 M68.86 M75.88 M75.41 M — EBITDA 137.76 M-127.89 M-128.43 M-84.82 M -98.28 M EBIT 130.53 M-138.05 M-137.11 M-92.55 M -114.05 M Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) 7.24 M10.16 M8.68 M7.72 M 15.77 M